-
Sudeep Pharma Shares Surge 75% Since IPO Price, but ICICI Securities Sets Target Below CMP: What Should Shareholders Do?
- October 14, 2026
- Posted by: Ankit Jaiswal
- Category: News
No Comments
Sudeep Pharma shares are about 71% to 75% above the issue price, but ICICI Securities keeps Hold with a Rs 1,000 target. See valuation, Q1 results and risks.
-
3 Pharma Ingredient Stocks With a Strong Future Roadmap: Acutaas Chemicals, Sudeep Pharma and Anthem Biosciences
- October 7, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Acutaas Chemicals, Sudeep Pharma and Anthem Biosciences compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
This Mineral Excipients Stock Rises 99% in 6 Months: What Doubled It
- September 23, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
A six-month gain of approximately 99% took a November 2025 listing from barely above its issue price to twice it. Here is what drove it, what it costs, and what still has to be built.